KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Gastroenterology / 2012 / Cilt: 23 - Sayı: 3

Myocarditis due to mesalamine treatment in a patient with Crohn’s disease in China

Yangyang LIU
Jianxin YE
Jianhong ZHU
Weichang CHEN
Ying SUN
Sayfa
304–306
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

LIU, Y., YE, J., ZHU, J., CHEN, W., SUN, Y. (2012). Myocarditis due to mesalamine treatment in a patient with Crohn’s disease in China. Turkish Journal of Gastroenterology, Cilt: 23 - Sayı: 3, 304–306. https://ajindex.com/articles/409660

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Sood A, Midha V, Sood N, et al. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003; 52: 1587-90
  2. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn’s disease in the Chinese population. Inflamm Bowel Dis 2004; 10: 646-51
  3. Tan YM, Goh KL. Ulcerative colitis in a multiracial Asian country: racial differences and clinical presentation in Malaysian patients. World J Gastroenterol 2005; 11: 5859-62
  4. Park JB, Yang SK, Myung SJ, et al. Familial occurrence of inflammatory bowel disease in Korea. Inflamm Bowel Dis 2006; 12: 1146-51
  5. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541-9
  6. Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human anti- tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial. Gastroenterology 2006; 130: 323-33; quiz 591
  7. Access Economics. The economic costs of Crohn’s disease and ulcerative colitis. Report for the Australian Crohn’s and Colitis Association 2007 June 9.